Kobiolabs

Bio & Pharma Kobiolabs gets Chinese patent for obesity treatment strain

South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...

Bio & Pharma Kobiolabs gets US patent for oral obesity drug candidate

Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...

Bio & Pharma Kobiolabs, Kakao Healthcare to explore microbiome-based precision medicine solutions

Kobiolabs Co., South Korea's new drug development company for microbiomes, announced on Tuesday that it has signed a memorandum of understanding for...